Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cibus, Inc. Director's Dealing 2018

Nov 13, 2018

34396_dirs_2018-11-13_15b80cf5-1062-482e-9bac-02515b299a91.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Calyxt, Inc. (CLXT)
CIK: 0001705843
Period of Report: 2018-11-08

Reporting Person: Voytas Daniel F (Chief Science Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-11-08 Common Stock M 4083 $3.7143 Acquired 97065 Direct
2018-11-08 Common Stock S 4083 $13.00 Disposed 92982 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-11-08 Stock Option (Right to Buy) $3.7143 M 4083 Disposed 2024-12-03 Common Stock (4083) Direct

Footnotes

F1: Includes 85,443 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and remain unvested; 15,078 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months.

F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F3: The stock option to purchase shares of Calyxt, Inc. common stock ("Stock Option") was granted on December 3, 2014, and vests 20% on January 3, 2015 and 20% on April 10, 2015, with the remainder vesting quarterly in equal installments over the following three years (or with an additional 25% vesting immediately if Calyxt, Inc. undergoes a change in control, liquidation, dissolution or initial public offering and the remainder vesting quarterly thereafter).